Eric Benevich

Companies

• aTyr PharmaBoard member Dec 12, 2024 to now¹
• Neurocrine BiosciencesChief Commerical Officer Jun 1, 2015 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Neurocrine Biosciences NBIX67,297 shares³$9.2M at $136.95Sep 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 11, 2026Shares withheld for tax 3,386 shares at $156.22 of Neurocrine Biosciences³
• Sep 11, 2026Granted 6,275 shares of Neurocrine Biosciences³
• Sep 9, 2026Sold 2,154 shares at $154.61 of Neurocrine Biosciences⁴
• Sep 9, 2026Exercised options 3,194 shares at $43.24 of Neurocrine Biosciences⁴
• Feb 13, 2026Shares withheld for tax 8,963 shares at $124.12 of Neurocrine Biosciences⁵
• Feb 13, 2026Granted 16,613 shares of Neurocrine Biosciences⁵
• Feb 13, 2026Shares withheld for tax 1,124 shares at $124.12 of Neurocrine Biosciences⁵
• Feb 13, 2026Exercised options 2,083 shares of Neurocrine Biosciences⁵
• Feb 13, 2026Shares withheld for tax 1,058 shares at $124.12 of Neurocrine Biosciences⁵
• Feb 13, 2026Exercised options 1,961 shares of Neurocrine Biosciences⁵
• Feb 12, 2026Shares withheld for tax 1,082 shares at $123.10 of Neurocrine Biosciences⁵
• Feb 12, 2026Exercised options 2,005 shares of Neurocrine Biosciences⁵
• Jan 31, 2026Shares withheld for tax 1,292 shares at $136.06 of Neurocrine Biosciences⁶
• Jan 31, 2026Exercised options 2,294 shares of Neurocrine Biosciences⁶
• Nov 28, 2025Sold 5,970 shares at $151.74 of Neurocrine Biosciences⁷
• Nov 28, 2025Exercised options 5,970 shares at $35.99 of Neurocrine Biosciences⁷
• Nov 28, 2025Exercised options 12,830 shares at $35.99 of Neurocrine Biosciences⁸
• Feb 13, 2025Sold 1,056 shares at $116.71 of Neurocrine Biosciences⁹
• Feb 13, 2025Exercised options 1,961 shares of Neurocrine Biosciences⁹
• Feb 13, 2025Sold 1,098 shares at $116.74 of Neurocrine Biosciences⁹
• Feb 13, 2025Exercised options 2,083 shares of Neurocrine Biosciences⁹
• Feb 10, 2025Sold 980 shares at $118.31 of Neurocrine Biosciences¹⁰
• Feb 8, 2025Exercised options 1,860 shares of Neurocrine Biosciences¹⁰
• Jan 31, 2025Sold 1,207 shares at $152.94 of Neurocrine Biosciences¹¹
• Jan 31, 2025Exercised options 2,294 shares of Neurocrine Biosciences¹¹